Neon Therapeutics is a clinical-stage immuno-oncology company and specializes in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. It develops therapies that target abnormal proteins called neoantigens, which are produced by cancer cells. Its programs are designed to leverage multiple facets of the immune response to elicit potent immune attack of tumors, with the aim of providing durable response to patients in need.